Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Main Authors: | Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Frontiers Media S.A.
2018-02-01
|
丛编: | Frontiers in Endocrinology |
主题: | |
在线阅读: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full |
相似书籍
-
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
由: Thomas Nyström, et al.
出版: (2017-11-01) -
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
由: J. Jendle, et al.
出版: (2021-12-01) -
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
由: Nikolai N. Scherbak, et al.
出版: (2023-09-01) -
Liraglutide overdose: A case report and an updated review
由: Sharafaldeen Bin Nafisah, et al.
出版: (2020-01-01) -
Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
由: Amir Shadboorestan, et al.
出版: (2022-04-01)